New Optical Technology Breakthroughs and Services in the UK Vision Scene.
Grafton Optical to sell new treatment equipment to UK Opticians to treat Dry Eye.
Grafton Optical to sell new treatment equipment to UK Opticians to treat Dry Eye
Exclusively available in the UK and Ireland through Grafton Optical, E-Eye uses patented IRPL® (Intense Regulated Pulsed Light) technology specifically designed for the treatment of Dry Eye due to Meibomian Gland Dysfunction (MGD).
E-Eye uses a unique patented Intense Regulated Pulsed Light (IRPL®) technology to help regenerate the function of the Meibomian glands and improve the quality of their secretions.
This new type of polychromatic pulsed light produces perfected calibrated and homogenously sequenced light pulses which stimulate the parasympathetic nerves. This in turn encourages the Meibomian glands to restore their natural lipid flow, reducing tear evaporation and preventing the eyes from becoming dry.
In most cases, Dry Eye symptoms will significantly improve after 3 sessions, carried out over 45 days (Day 0/ Day 15/ Day 45). For 60% of patients results can last up to 3 years.
• Painless, non-invasive and affordable
• Fast results – sessions are completed in a matter of minutes
• Clinical studies with a 90% satisfaction rate on the first 2 sessions
• 95.7% of patients recommend the treatment
• 55% of patients don’t use eye drops anymore
• 82.6% of patients have symptom improvements
Brian Bowles, Managing Director of Grafton Optical says “We have seen huge interest and success with the E-Eye since its launch in the UK last year. It offers huge benefits to patients suffering from MGD related Dry Eye. ”
E-Eye is 100% developed and made in France by ESW Vision, the world’s largest IPL device manufacturer.
PHN kindly thanks Grafton for their Sponsorship, sponsors allow the free publication of this independent news source to over 1000 readers every day to My Local Optician.